Haematology Flashcards

1
Q

Blood film - splenectomy

A
  • Howell-Jolly bodies - nuclear fragments in RBC
  • Acanthocytes - spur cells, thorn/spicules at irregular intervals on surface of RBC
  • Target cells - central density with halo of pallor in RBC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Blood film - iron deficiency anaemia (IDA)

A
  • Microcyctic (small) RBC
  • Hypochromic (thin rim of pink) RBC
  • Poikilocytosis - abnormal shaped RBC, eg. “pencil” shaped cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blood film - hypothyroidism

A
  • Normocytic, normochromic, hypoproliferative, anaemia

- In chronic autoimmune thyroiditis - pernicious anaemia (macrocytic, marrow megaloblastosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood film - B12 and folate deficiency

A
  • Macrocytosis - macro-ovalocytes, occasional megaloblast
  • Teardrop cells
  • Hypersegmented neutrophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Coagulation studies - acquired factor VIII inhibitor

A

Prolonged APTT

Mixing test - corrects initially, no correction in 2 hour incubation (characteristic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Haemophilia A

A

Congenital factor VIII deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Haemophilia B

A

Congenital factor IX deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most common haemophilia bleeding sites

A

Haemarthrosis (70-80%) - primarily knee and elbow
Muscle / soft tissue (10-20%)
Other major bleed (5-10%)
CNS bleed (rare, less than 5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most common Von Willebrand disease bleeding sites

A

Bruising
Skin bleeding
Mucosal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Coagulation studies - disseminated intravascular coagulation (DIC)

A

Prolonged APTT
Prolonged PT/INR
Low fibrinogen
High d-dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Coagulation studies - heparin

A
Prolonged TCT (thrombin clotting time)
Normal reptilase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coagulation studies - dysfibrinogenaemia

A

Prolonged TCT

Prolonged reptilase test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lugano classification (for non-Hodgkin’s lymphoma)

A

Stage I - disease on one side of diaphragm
Stage II - more than one area same side diaphragm
Stage III - lymph nodes above and below diaphragm
Stage IV - extranodular disease
E = extranodal contiguous extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Choice of treatment modality in non-Hodgkin’s lymphoma

A

Based on Lugano classification:
Stage I - radiotherapy (curative in 50%)
Stage II - consider radiotherapy if low bulk and within field, otherwise treat as advanced
Stage III/IV (advanced) - chemooimmunotherapy ± radiotherapy, for symptom control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intravascular haemolysis - investigations

A

Presence of urine haemosiderin - most specific
Increased LDH
Increased bilirubin
Decreased haptoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most common lymphoproliferative disorders associated with Epstein-Barr virus (EBV)

A

Hodgkin’s lymphoma

Burkitt’s lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cytogenetics - follicular lymphoma

A

t(14;18) - bcl-2 / IgH

overexpression of BCL-2, an anti-apoptosis protein

18
Q

Cytogenetics - diffuse large B-cell lymphoma (DLBCL)

A

No single typical abnormality.
BCL-6 - chromosome 3, numerous alterations seen
t(14;18) - bcl-2 (30%)
t(8;14) - c-MYC (5-15%)

19
Q

Cytogenetics - mantle cell lymphoma

A

t(11;14) - cyclin D1 / IgH

abnormal dysregulated expression of cyclin D1 in B lymphocytes, involved in control of G1 phase of cell cycle

20
Q

Cytogenetics - Burkitt lymphoma

A

t(8;14) - 80%, c-MYC / IgH
t(2;8) and t(8;22) - also seen

(c-MYC dysregulation driven by IgH enhancer)

21
Q

Cytogenetics - acute myeloid leukaemia (AML)

A

Recurrent genetic abnormalities in 11% of cases.
t(8;21) - 7% adults, most frequent in children
t(16;16), inv(16) - 5% adults, chromosome 16 abnormality

22
Q

Cytogenetics - acute promyeloid leukaemia (APL)

A

t(15;17) - PML-RARA fusion protein

aberrant retinoid receptor with altered DNA binding and transcriptional regulatory properties

23
Q

Cytogenetics - acute lymphocytic leukaemia (ALL)

A

Hyperdiploidy - more than 46 chromosomes

t(9;22) - confers worse prognosis

24
Q

Cytogenetics - chronic myeloid leukaemia (CML)

A

t(9;22) - Philadelphia chromosome

bcr-abl leads to increased PO4 of TK residues on substrates, switches on signalling pathways

25
Cytogenetics - chronic lymphocytic leukaemia (CLL)
del(17p) - 7-10%, worse prognosis del(11q) - 17-20%, worse prognosis TP53 mutation - 10-47%, worse prognosis del(13q) - 45-55%, favourable prognosis
26
Blood film - primary myelofibrosis
- Teardrop cells (dacrocytes) - Poikilocytosis - abnormal shaped RBC - Nucleated RBC - Leukopenia/ thrombocytopenia (can have leukocytosis/ thrombocytosis)
27
Most common myeloproliferative disorder associated with Budd Chiari syndrome
Polycythaemia rubra vera (PCV)
28
Blood film - myelodysplasia
- Anaemia (with anisocytosis) - Leukopenia - Thrombocytopenia (can transform to AML)
29
Polycythaemia rubra vera (PRV) - diagnostic criteria
WHO critera - 2 major + 1 minor, or 1 major + 2 minor Major: - Hb more than 185 men, 165 women - JAK2 mutation present Minor: - Bone marrow biopsy (hypercellularity, trilineage growth) - Serum EPO level low - Endogenous erythroid colony formation in vitro
30
Myelodysplastic syndrome (MDS) - treatment
Azacitidine | Lenalidomide - in deletion 5q
31
Blood film - autoimmune haemolytic anaemia (AIHA)
- Spherocytes - dark red, sphere shaped RBC (rather than biconcave) - Microspherocytes - dark red, small spherocyte
32
Blood film - microangiopathic haemolytic anaemia (MAHA)
- Schistocytes - fragmented RBC including helmet cells, triangle cells - Helmet cells - RBC shaped as bicycle, combat or football helmets (Seen in TTP, HUS)
33
Blood film - thalsassaemia
- Target cells - central density with halo of pallor - Hypochromia - Microcytosis - Teardrop cells - Basophilic stippling - blue granules on RBC
34
Blood film - liver disease
- Target cells - central density with pale halo (due to membrane excess)
35
Thrombotic thrombocytopenic purpura (TTP) - presentation
- Microangiopathic haemolytic anaemia - Thrombocytopenia - Fever - Neurological manifestations - Minimal renal abnormalities
36
Haemolytic uraemic syndrome (HUS) - presentation
- Microangiopathic haemolytic anaemia - Thrombocytopenia - Acute kidney injury - Bloody diarrhoea - in typical (secondary) HUS
37
ADAMTS13 (A Disintegrin And Metalloprotease with a ThromboSpondin type 1 motif, member 13) deficiency
- Causes TTP - Activity level <10% - Due to ADAMTS13 gene mutation, or inhibitory antibodies
38
Plasma exchange / plasmapheresis - indications
- Guillain-Barre syndrome - ANCA RPGN - Anti-GBM (Goodpasture's) - CIDP - Cryoglobulinaemia - FSGN - Atypical HUS - TTP - Wilson's disease - Hyperviscosity in monoclonal gammopathy - Renal or liver transplantation - desensitization, Ab rejection - Myasthenia gravis - PANDAS - Paraproteinemic polyneuropathy
39
Promoter of neutrophil production
G-CSF (granulocyte colony stimulating factor)
40
Promoter of platelet production
TPO (thrombopoietin)
41
Heparin - mechanism of action
- Binds and activates anti-thrombin III - Activated ATIII inactivates other factors (mainly Xa) - Simultaneous binding of ATIII and thrombin to inactivate thrombin (LMWH cannot do this)
42
Protein C - mechanism of action
- Activated by thrombin-thrombomodulin complex - Protein S is co-factor for activation - Activated protein C (APC) inactivates factor V and VIII